Infant Bacterial Therapeutics
49.35 SEK
+0.71 %
Less than 1K followers
IBT B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Infant Bacterial Therapeutics
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 143.00 | 112.00 | 66.80 | 50.00 | 90.00 | 53.60 | 50.50 |
| Shares | 11.2 | 11.2 | 11.2 | 11.2 | 13.5 | 13.5 | 13.5 |
| Market cap | 1,605.3 | 1,257.3 | 749.9 | 561.3 | 1,212.4 | 722.1 | 680.3 |
| Enterprise value | 1,110.1 | 833.9 | 363.1 | 225.5 | 883.4 | 498.7 | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.15 | 2.86 | 1.90 | 1.69 | 3.97 | 4.24 | 6.46 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 98.5 % | 97.7 % | 96.8 % | 94.9 % | 86.9 % | 71.1 % | 65.1 % |
| Gearing ratio | - | - | - | - | - | - | - |